Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OxLDL-mediated immunologic memory in endothelial cells.
Sohrabi Y, Lagache SMM, Voges VC, Semo D, Sonntag G, Hanemann I, Kahles F, Waltenberger J, Findeisen HM. Sohrabi Y, et al. Among authors: semo d. J Mol Cell Cardiol. 2020 Sep;146:121-132. doi: 10.1016/j.yjmcc.2020.07.006. Epub 2020 Jul 26. J Mol Cell Cardiol. 2020. PMID: 32726647
Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis.
Jirak P, van Almsick V, Dimitroulis D, Mirna M, Seelmaier C, Shomanova Z, Wernly B, Semo D, Dankl D, Mahringer M, Lichtenauer M, Hoppe UC, Reinecke H, Pistulli R, Larbig R, Motloch LJ. Jirak P, et al. Among authors: semo d. Front Med (Lausanne). 2022 Feb 2;9:808221. doi: 10.3389/fmed.2022.808221. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35186995 Free PMC article.
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine.
Ohnewein B, Shomanova Z, Paar V, Topf A, Jirak P, Fiedler L, Granitz C, Van Almsick V, Semo D, Zagidullin N, Dieplinger AM, Sindermann J, Reinecke H, Hoppe UC, Pistulli R, Motloch LJ. Ohnewein B, et al. Among authors: semo d. J Clin Med. 2023 Apr 24;12(9):3083. doi: 10.3390/jcm12093083. J Clin Med. 2023. PMID: 37176525 Free PMC article.
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms.
Semo D, Obergassel J, Dorenkamp M, Hemling P, Strutz J, Hiden U, Müller N, Müller UA, Zulfikar SA, Godfrey R, Waltenberger J. Semo D, et al. J Clin Med. 2023 Feb 8;12(4):1356. doi: 10.3390/jcm12041356. J Clin Med. 2023. PMID: 36835891 Free PMC article.